Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Shareholders held by Focus Universal Inc. on June 20, 2025. The company is incorporated in Nevada and its common stock trades on the Nasdaq Capital Market under the symbol FCUV. As of the record date (April 21, 2025), there were 7,124,013 shares of common stock outstanding, with 5,555,398 shares represented at the meeting, establishing a quorum.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and shareholder voting results. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent Form 10-K or 10-Q for financial statements.
Material Changes and Voting Results
Shareholders voted on six proposals. All proposals were approved, though some received significant dissenting votes.
- Proposal 1 (Election of Directors): All five nominees were elected. However, significant "Votes Against" were cast for three directors: Michael Pope (137,257), Carine Clark (133,364), and Sean Warren (133,607). Dr. Desheng Wang and Dr. Edward Lee received minimal opposition.
- Proposal 2 (Auditor Ratification): Shareholders ratified the appointment of Weinberg & Company, P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Proposal 3 (Increase Authorized Common Stock): Approved an amendment to increase authorized common stock from 15,000,000 to 25,000,000 shares. Approximately 2% of votes were cast against.
- Proposal 4 (Authorize Preferred Stock): Approved the authorization of 5,000,000 shares of preferred stock. Approximately 2.7% of votes were cast against.
- Proposal 5 (Say on Pay): Approved executive compensation on a non-binding advisory basis with overwhelming support (98.5% For).
- Proposal 6 (Say on Frequency): Shareholders voted to hold the advisory vote on executive compensation annually (1-year frequency), with 4,130,023 votes for 1 year versus 561,242 for 3 years.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are disclosed in this document other than the standard governance risks implied by the voting results.
Investor Verification Checklist
- Verify the reasons for the significant "Votes Against" cast for directors Michael Pope, Carine Clark, and Sean Warren.
- Confirm the specific terms and rights of the newly authorized 5,000,000 shares of preferred stock, as these are subject to Board discretion.
- Review the company's latest 10-K or 10-Q for financial health, as this 8-K contains no financial data.
- Monitor future filings for the formal adoption of the Articles of Incorporation amendments regarding share authorization.